Opinion
Video
Author(s):
An expert discusses the clinical presentation and diagnosis of immune thrombocytopenic purpura (ITP), emphasizing that isolated thrombocytopenia with mucosal bleeding and petechiae is highly suggestive of ITP, while underscoring the importance of ruling out other causes—especially drug-induced thrombocytopenia—through careful evaluation.
The most common clinical sign of immune thrombocytopenic purpura (ITP) is a low platelet count. When platelet levels decrease, patients may begin to exhibit bleeding symptoms, which vary based on the severity of the thrombocytopenia. Mucosal bleeding is particularly common, especially nosebleeds. Additionally, patients often present with purpura, notably petechiae on the lower extremities. In more severe cases, when platelet counts fall into the single digits, larger purpuric lesions may appear inside the mouth.
A key diagnostic clue for ITP is that a low platelet count may be the sole abnormality in a patient’s complete blood count (CBC). White blood cell count and hemoglobin levels are often within normal ranges. Furthermore, the differential does not usually raise any red flags. Because of this, ITP is considered a diagnosis of exclusion. Physicians must rule out other potential causes of low platelets, especially external factors like new medications or therapies that could impact platelet production or survival.
Despite being a diagnosis of exclusion, a patient presenting with isolated thrombocytopenia and bleeding symptoms is strongly suggestive of ITP. However, careful clinical evaluation is essential to ensure no other underlying condition is responsible. Drug-induced thrombocytopenia is one of the most common alternate diagnoses to consider, particularly if the patient has recently initiated a new treatment. Ultimately, while mucosal bleeding and petechiae are hallmark features, it is the pattern of isolated low platelet count that provides the strongest indication of ITP.
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.